Free Account Opening + AMC Free Demat
Loading...

Supriya Lifescience IPO vs Manyavar IPO

Comparision between Supriya Lifescience IPO and Manyavar IPO.

IPO Details

Supriya Lifescience IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Manyavar IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Supriya Lifescience IPO is up to ₹700.00 Cr whereas the issue size of the Manyavar IPO is up to ₹3,149.19 Cr. The final issue price of Supriya Lifescience IPO is ₹274.00 per share and of Manyavar IPO is ₹866.00 per share.

  Supriya Lifescience IPO Manyavar IPO
Face Value ₹2 per share ₹1 per share
Issue Price (Lower) ₹265.00 per share ₹824.00 per share
Issue Price (Upper) ₹274.00 per share ₹866.00 per share
Issue Price (Final) ₹274.00 per share ₹866.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 54 shares 17 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹200.00 Cr
OFS Issue Size 3,63,64,838 shares
OFS Issue Size (Amount) up to ₹500.00 Cr up to ₹3,149.19 Cr
Issue Size Total 3,63,64,838 shares
Issue Size Total (Amount) up to ₹700.00 Cr up to ₹3,149.19 Cr

IPO Timetable

Supriya Lifescience IPO opens on Dec 16, 2021, while Manyavar IPO opens on Feb 04, 2022. The closing date of Supriya Lifescience IPO and Manyavar IPO is Dec 20, 2021, and Feb 08, 2022, respectively.

  Supriya Lifescience IPO Manyavar IPO
Anchor Bid Date
Issue Open Dec 16, 2021 Feb 04, 2022
Issue Close Dec 20, 2021 Feb 08, 2022
Basis Of Allotment (Tentative) Dec 23, 2021 Feb 11, 2022
Initiation of Refunds (Tentative) Dec 24, 2021 Feb 14, 2022
Credit of Share (Tentative) Dec 27, 2021 Feb 15, 2022
Listing date (Tentative) Dec 28, 2021 Feb 16, 2022
Anchor Lockin End date 1 Jan 22, 2022 Mar 13, 2022
Anchor Lockin End date 2 Mar 23, 2022 May 12, 2022

Financials

Supriya Lifescience IPO P/E ratio is , as compared to Manyavar IPO P/E ratio of 106.78.

  Supriya Lifescience IPO Manyavar IPO
Financial
Summary of financial Information (Restated Standalone)
Particulars For the year/period ended (₹ in Millions)
  30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 5,041.02 4,458.24 3,364.01 2,530.52
Total Revenue 2,300.61 3,962.21 3,227.13 2,858.62
Profit After Tax 659.59 1,238.28 733.74 394.24
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
  30-Sep-21 31-Mar-21 31-Mar-20
Total Assets 14,455.03 16,256.53 15,915.53
Total Revenue 3,872.90 6,250.19 9,479.76
Profit After Tax 984.07 1,329.03 2,366.37
Promoter Shareholding (Pre-Issue) 99.98% 92.40%
Promoter Shareholding (Post-Issue) 68.24% 84.9%
P/E Ratio 106.78
Market Cap ₹21017.37 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Supriya Lifescience IPO retail investors (RII) are offered 26,41,509 shares while in Manyavar IPO retail investors are offered 26,41,509 shares. Qualified institutional buyers (QIB) are offered 79,24,527 shares in Supriya Lifescience IPO and 72,72,968 shares in Manyavar IPO.

  Supriya Lifescience IPO Manyavar IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 79,24,527 shares 72,72,968 shares
NII 39,62,263 shares 54,54,726 shares
RII 26,41,509 shares 1,27,27,694 shares
Employee 0 shares 0 shares
Others
Total 1,45,28,299 shares 2,54,55,388 shares

Bids Received (Subscription)

Supriya Lifescience IPO subscribed 71.51x in total, whereas Manyavar IPO subscribed 2.57x.

  Supriya Lifescience IPO Manyavar IPO
QIB (times) 31.83x 7.49x
NII (times) 161.22x 1.07x
Big NII (times)
Small NII (times)
RII (times) 56.01x 0.39x
Employee (times)
Other (times)
Total (times) 71.51x 2.57x

Comments

Add a public comment...